<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Vaccines and Antivirals | Medical Virology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts - Inter for UI, Source Serif for reading -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- KaTeX for Math rendering -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js" onload="renderMathInElement(document.body, {
        delimiters: [
            {left: '$$', right: '$$', display: true},
            {left: '$', right: '$', display: false}
        ]
    });"></script>
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Theme Toggle (Fixed Position) -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Reading Progress Bar -->
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                
                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-03-diagnosis.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="#" class="nav-button nav-button--next disabled" aria-disabled="true">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                        <span class="progress-text">Topic 4 of 4</span>
                    </div>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span>üõ°Ô∏è</span>
                        <span>Topic 04</span>
                    </div>
                    <h1 class="document-title">Virus Vaccines and Antiviral Therapeutic Agents</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Chapter 4</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>15 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: vaccines-intro -->
                    <section class="content-section" id="vaccines-intro">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Classification of Vaccines
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Vaccines are available for the prevention of many human viral diseases. Vaccines may be classified into three groups:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Killed virus vaccine</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Live attenuated virus vaccine</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Recombinant DNA produced vaccine.</span>
                                </li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: vaccines-intro -->

                    <!-- START: killed-vaccines -->
                    <section class="content-section" id="killed-vaccines">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö∞Ô∏è</span>
                                Killed Virus Vaccines
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Killed virus vaccines are prepared by purifying virus cultures and then inactivating the viral infectivity in such a way that there is minimal damage to virus structural proteins. Mild formalin treatment is frequently used for this purpose. Killed virus vaccines generally result in stimulation of antibodies against virus coat proteins. These vaccines are available for viral infections such as polio, rabies, influenza, hepatitis A and some encephalitis viruses.</p>

                            <h3>Disadvantages of Killed Vaccines</h3>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Immunity conferred by killed viral vaccines is usually brief, and needs to be boosted.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The cell-mediated immune response is generally poor.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Parenteral administration of killed vaccine may not stimulate IgA to provide local resistance at the site of infection, e.g. alimentary tract for polio virus, nasopharynx for respiratory viruses.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Some killed vaccines can induce hypersensitivity to subsequent infection as the surface antigens of virus in killed vaccine may not be exactly the same as in infection with the natural virus.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">It is necessary to be extremely careful in the preparation so that there is no residual live virulent virus in the vaccine.</span>
                                </li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: killed-vaccines -->

                    <!-- START: live-vaccines -->
                    <section class="content-section" id="live-vaccines">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü¶†</span>
                                Live Attenuated Virus Vaccines
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Live virus vaccines make use of virus mutants which are antigenically identical with the original virus but have lost virulence. The search for such strains is done by planned, specific, genetic alterations in the laboratory. Live attenuated vaccine, when introduced into the body can simulate natural infection. The virus multiplies in the host resulting in long lasting antibody production, and induces a good cell-mediated immune response. Examples of live attenuated vaccines in use are polio, mumps, measles, rubella, adenovirus and yellow fever vaccines.</p>

                            <h3>Disadvantages of Live Attenuated Vaccines</h3>
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Risks and Limitations</h4>
                                </div>
                                <div class="callout-content">
                                    <p>The attenuated virus may revert to its virulent form while in the body of the host.</p>
                                    <p>Other infectious agents latently present in cell cultures may enter the vaccine.</p>
                                    <p>Attenuated viral vaccines have a limited shelf-life. Viral stabilizers are used in some vaccines.</p>
                                    <p>A naturally occurring virus already present in the body may interfere with the vaccine virus, and so decrease its effectiveness.</p>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: live-vaccines -->

                    <!-- START: recombinant-vaccines -->
                    <section class="content-section" id="recombinant-vaccines">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Recombinant DNA Vaccine
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>This is a new vaccine for immunisation against Hepatitis B infection. The recombinant vaccine is produced by common baker's yeast, <em>Saccharomyces cerevisiae</em>, into which a plasmid containing the gene for HBsAg has been inserted. HBsAg is recovered by lysing the yeast cells and is separated from yeast components by hydrophobic reaction and size-exclusion chromatography.</p>
                            <p>The recombinant vaccine is comparable to the plasma-derived vaccine in immunogenicity. This is a recent technology that is not in common use.</p>
                        </div>
                    </section>
                    <!-- END: recombinant-vaccines -->

                    <!-- START: vaccines-table -->
                    <section class="content-section" id="vaccines-table">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìä</span>
                                Vaccines for Prevention of Human Viral Diseases
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Some vaccines used in prevention of human viral diseases are listed in Table 4.1.</p>
                            
                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üíâ</span>
                                    <span class="table-caption">Table 4.1 Vaccines for prevention of human viral diseases</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table comparison-table">
                                        <thead>
                                            <tr>
                                                <th>Diseases</th>
                                                <th>Source of vaccine</th>
                                                <th>Condition of virus</th>
                                                <th>Route of administration</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Poliomyelitis</strong></td>
                                                <td>Tissue culture (human diploid cell line, monkey kidney)</td>
                                                <td>Live attenuated<br>Killed</td>
                                                <td>Oral<br>Subcutaneous</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Measles</strong></td>
                                                <td>Tissue culture (chick embryo)</td>
                                                <td>Live attenuated</td>
                                                <td>Subcutaneous</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Mumps</strong></td>
                                                <td>Tissue culture (chick embryo)</td>
                                                <td>Live attenuated</td>
                                                <td>Subcutaneous</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Rubella</strong></td>
                                                <td>Tissue culture (duck embryo, rabbit or human diploid)</td>
                                                <td>Live attenuated</td>
                                                <td>Subcutaneous</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Small pox</strong></td>
                                                <td>Lymph from calf or sheep (glycerolated, lyophilized) chorioallantois, tissue cultures (lyophilized)</td>
                                                <td>Live vaccinia virus</td>
                                                <td>Intradermal, multiple pressure, multiple puncture</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Yellow fever</strong></td>
                                                <td>Tissue cultures and eggs (17D strain)</td>
                                                <td>Live attenuated</td>
                                                <td>Subcutaneous</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Hepatitis type B</strong></td>
                                                <td>(i) Purified HBsAg from "healthy carriers"<br>(ii) Purified HBsAg obtained by recombinant DNA technology</td>
                                                <td>Killed<br>Killed</td>
                                                <td>Subcutaneous<br>Intramuscular</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Influenza</strong></td>
                                                <td>Highly purified or subunit forms of chick embryo allantoic fluid (formalin-treated or UV-irradiated)</td>
                                                <td>Killed</td>
                                                <td>Subcutaneous or intradermal</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Rabies</strong></td>
                                                <td>Duck embryo or human diploid cells</td>
                                                <td>Killed</td>
                                                <td>Subcutaneous</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Adenovirus Infections</strong></td>
                                                <td>Human diploid cells cultures</td>
                                                <td>Live attenuated</td>
                                                <td>Oral, by enteric-coated capsule</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: vaccines-table -->

                    <!-- START: antiviral-agents -->
                    <section class="content-section" id="antiviral-agents">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Antiviral Therapeutic Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3 id="interferons">Interferons</h3>
                            <p>Interferons (IFN) are proteins produced by the host which can inhibit virus replication. They are believed to be body's first line of defense against viral infection. Interferons fall into three general groups, IFN-Œ±, IFN-Œ≤ and IFN-Œ≥, and are produced by all vertebrate species when they are induced to do so by viruses. Bacterial endotoxins and some small molecules such as tilorone also induce interferons.</p>
                            <p>The different classes of interferons are produced by different cell types, e.g. IFN-Œ± are produced by leukocytes, IFN-Œ≤ by fibroblasts and IFN-Œ≥ by lymphocytes. Interferons are produced within 48 hours of viral infection and reduce the rate of multiplication of the virus. Virus specific antibody on the other hand, appears in hosts' blood several days after virus entry. Interferon therefore, plays a primary role in host defense against viral infections.</p>
                            <p>Interferon activity is not specific for a virus. The mechanism of its action is poorly understood. It binds to surface receptors in a cell which triggers the synthesis of several enzymes. These enzymes block viral multiplication by inhibiting the translation of viral mRNA into viral protein. Interferons are also involved in regulation of cell growth and differentiation. They enhance natural killer cell activity in the body.</p>
                            <p>Interferons are not generally used for protection against viral infection because they need to be given in high doses at which they exhibit toxic side effects such as bone marrow suppression. They may also affect nervous and gastrointestinal systems.</p>

                            <h3 id="immune-globulin">Immune Globulin</h3>
                            <p>It is a preparation of gamma globulin derived from large pools of human plasma, and contains a high concentration of antibody containing globulins. Immune globulin can be used clinically in viral diseases such as measles and hepatitis A to attenuate the disease and to prevent clinical disease in non-immunized children.</p>

                            <h3 id="specific-gamma-globulins">Specific Human Gamma Globulins</h3>
                            <p>These are obtained from the blood of individuals who have been immunized with a given antigen and have acquired a high concentration of specific antibody. It is found to be effective against rabies, mumps, chicken-pox and hepatitis B infection.</p>

                            <h3 id="anti-viral-drugs">Anti-viral Drugs</h3>
                            <p>As viruses are obligate intracellular parasites, antiviral agents must be capable of selectively inhibiting viral functions without damaging the host cells. The majority of antiviral drugs in use are nucleoside analogs. They inhibit nucleic acid replication by (1) inhibition of enzymes of the metabolic pathway for purines and pyrimidines, or (2) by inhibition of polymerases for nucleic acid replication. However, these analogs can inhibit virus coded enzymes as well as enzymes of the host cell. They can be used for antiviral treatment only if the benefit of virus inhibition is greater than its toxicity to the host cell.</p>
                            
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Acyclovir</h4>
                                    <p>Acyclovir is an analog of guanosine which strongly inhibits herpes simplex virus, but has little effect on other DNA viruses or on host cells.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Vidarabine</h4>
                                    <p>Vidarabine is a purine analog effective against herpes simplex and varicella zoster infections.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Amantatidine</h4>
                                    <p>Amantatidine is effective against influenza A virus and acts by blocking viral penetration into the host cell.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Enviroxine</h4>
                                    <p>Enviroxine inhibits rhinovirus in cell culture and reduces common cold symptoms in human hosts.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Anti-HIV Drugs</h4>
                                    <p>Acidothymidine (Zidovudine), dideoxycytosine (ddc) and dideoxyinosine (ddI) are nucleoside analogs which inhibit reverse transcriptase enzyme of HIV.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Other Drugs</h4>
                                    <p>Other drugs include Arildone, Methisazone and Phosphonoacetic acid. Drugs such as Idoxuridine, Trifluridine, Ribavirin etc. also have similar effects. Some are useful only for topical application.</p>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: antiviral-agents -->

                    <!-- Key Points Section -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Killed virus vaccines generally result in stimulation of antibodies against virus coat proteins.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Live virus vaccines make use of virus mutants which are antigenically identical with the original virus but have lost virulence.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Interferons (IFN) are proteins produced by the host which can inhibit virus replication. They are believed to be body's first line of defense against viral infection.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>The majority of antiviral drugs in use are nucleoside analogs.</strong></p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </main>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-03-diagnosis.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="#" class="nav-button nav-button--next disabled" aria-disabled="true">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                        <span class="progress-text">Topic 4 of 4</span>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog" aria-label="Image viewer">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>